Solid biosciences appoints kevin tan, cfa, as chief financial officer

Charlestown, mass., jan. 09, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced the appointment of kevin tan, cfa, a seasoned industry professional, as chief financial officer.
SLDB Ratings Summary
SLDB Quant Ranking